AtlasMedx seeks appropriate enabling partnership opportunities to enhance and accelerate its unique approach to small molecule drug discovery and development.

We are exceptionally positioned with our leading scientific and clinical approach in developing transformational anti-cancer drugs that provides:

An in-depth understanding of clinical oncology and cellular cancer biology

A portfolio of novel multifunctional drugs that simultaneously target compensatory mechanisms pertinent to carcinogenesis and resistance to chemotherapy

A strong IP position covering the major pharmaceutical markets worldwide

A top-level management team and scientific and clinical advisory board with extensive experience, expertise, and credibility in biopharmaceutical industry, drug development, cancer biology, clinical oncology, clinical trials, and patient care management


For partnering opportunities:

1700 4th St, QB3
Byers Hall 214, MC 2522,
San Francisco, CA 94158